Growth Metrics

Teladoc Health (TDOC) Gains from Investment Securities (2016 - 2025)

Teladoc Health (TDOC) has disclosed Gains from Investment Securities for 13 consecutive years, with -$12.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 235.97% to -$12.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.4 million through Dec 2025, down 171.53% year-over-year, with the annual reading at -$6.4 million for FY2025, 171.53% down from the prior year.
  • Gains from Investment Securities hit -$12.2 million in Q4 2025 for Teladoc Health, down from $7.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $15.3 million in Q2 2022 to a low of -$12.2 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $3.1 million across 5 years, with a median of $2.7 million in 2022.
  • Biggest YoY gain for Gains from Investment Securities was 9134.3% in 2023; the steepest drop was 643.25% in 2023.
  • Year by year, Gains from Investment Securities stood at -$1.9 million in 2021, then surged by 160.35% to $1.2 million in 2022, then crashed by 643.25% to -$6.3 million in 2023, then soared by 241.6% to $8.9 million in 2024, then crashed by 235.97% to -$12.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for TDOC at -$12.2 million in Q4 2025, $7.8 million in Q3 2025, and -$2.4 million in Q2 2025.